In gliomas, for instance, it has been reported that mutations in the IDH (isocitrate dehydrogenase genes 1 and 2, collectively referred to as IDH) genes result in the hyper-methylation of a number of sites [14]. This evidence concerns the gene IDH2 and glioma.